Status:
COMPLETED
Additional Signals for Exercise, Stress and Sleep and Prediction of Glucose Levels for AP Systems
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
Illinois Institute of Technology
University of Chicago
Conditions:
Type1 Diabetes Mellitus
Eligibility:
All Genders
18-60 years
Brief Summary
The objective of this research is to determine the most informative variables for detecting exercise, acute stress and sleep, identify select sensors that report these variables, and develop the algor...
Detailed Description
The focus of the proposed work is to determine the most informative variables for meals, exercise, acute stress and sleep (MESS), identify select sensors that report these variables, and develop the a...
Eligibility Criteria
Inclusion
- Men and Women with T1DM
- 18-60 years of age
- Insulin pump user
Exclusion
- Metabolic instability as evidenced by hospitalizations for diabetes or other diabetes-related complications (e.g., diabetic ketoacidosis and hypoglycemic seizures) within the preceding three months;
- Severe macrovascular disease, as evidenced by severe peripheral artery disease; history of myocardial infarction, heart failure, thromboembolic disease, or unstable angina; uncontrolled hypertension; abnormal resting EKG;
- Maximal exercise stress test with significant brady/tachy arrhythmia, ectopic beats, bundle branch block, or signs of acute ischemia;
- Severe microvascular disease as evidenced by history of vision-threatening proliferative or non-proliferative retinal disease; kidney disease;
- Any uncontrolled non-musculoskeletal condition that would limit the subject's ability to participate in the exercise program (e.g., chronic obstructive airways disease);
- Musculoskeletal conditions such as neurological or orthopedic conditions affecting lower limb strength and mobility (e.g., stroke; insensitive foot);
- Pregnancy;
- Documented medical condition or physical impairment that is judged by the health care practitioner to contraindicate exercise.
Key Trial Info
Start Date :
May 24 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 13 2021
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04725799
Start Date
May 24 2018
End Date
July 13 2021
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612